1. Home
  2. JWEL vs VRAX Comparison

JWEL vs VRAX Comparison

Compare JWEL & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JWEL
  • VRAX
  • Stock Information
  • Founded
  • JWEL 2012
  • VRAX 2013
  • Country
  • JWEL China
  • VRAX United Kingdom
  • Employees
  • JWEL N/A
  • VRAX N/A
  • Industry
  • JWEL Other Consumer Services
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • JWEL Consumer Discretionary
  • VRAX Health Care
  • Exchange
  • JWEL Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • JWEL 4.1M
  • VRAX 4.4M
  • IPO Year
  • JWEL 2021
  • VRAX 2022
  • Fundamental
  • Price
  • JWEL $1.73
  • VRAX $0.65
  • Analyst Decision
  • JWEL
  • VRAX Strong Buy
  • Analyst Count
  • JWEL 0
  • VRAX 1
  • Target Price
  • JWEL N/A
  • VRAX $3.00
  • AVG Volume (30 Days)
  • JWEL 23.4K
  • VRAX 1.4M
  • Earning Date
  • JWEL 05-09-2025
  • VRAX 01-01-0001
  • Dividend Yield
  • JWEL N/A
  • VRAX N/A
  • EPS Growth
  • JWEL N/A
  • VRAX N/A
  • EPS
  • JWEL N/A
  • VRAX N/A
  • Revenue
  • JWEL $132,981,531.00
  • VRAX $6,331.00
  • Revenue This Year
  • JWEL N/A
  • VRAX $217,274.83
  • Revenue Next Year
  • JWEL N/A
  • VRAX N/A
  • P/E Ratio
  • JWEL N/A
  • VRAX N/A
  • Revenue Growth
  • JWEL N/A
  • VRAX N/A
  • 52 Week Low
  • JWEL $1.20
  • VRAX $0.52
  • 52 Week High
  • JWEL $3.71
  • VRAX $3.62
  • Technical
  • Relative Strength Index (RSI)
  • JWEL 41.57
  • VRAX 45.86
  • Support Level
  • JWEL $1.50
  • VRAX $0.54
  • Resistance Level
  • JWEL $1.88
  • VRAX $0.59
  • Average True Range (ATR)
  • JWEL 0.16
  • VRAX 0.06
  • MACD
  • JWEL -0.01
  • VRAX 0.01
  • Stochastic Oscillator
  • JWEL 31.59
  • VRAX 50.76

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: